Lin Song currently serves as the Director of Regulatory Affairs & Labeling at Stryker Orthopaedics, where responsibilities include overseeing implant regulatory strategies and submissions for the Joint Replacement Division to ensure global market compliance. With extensive experience in regulatory affairs and R&D, Lin Song has progressed through various roles at Stryker since 2006, including Senior Manager roles in Regulatory Affairs and R&D, and positions as Manager and Supervising Senior Scientist, focusing on polymer technology and Orthobiologics product development. Prior to joining Stryker, Lin Song was a Research Fellow at the National Institutes of Health, conducting stem cell research for orthopedic applications and supervising students and technicians. Lin Song holds a PhD in Cell Biology & Physiology from The University of Kansas.
This person is not in any teams
This person is not in any offices